We see CPMC's cost pressure can be managed through its pricing mechanism and mitigate by the solid volume growth. The stock's 0.85x P/B is well justified by the uptrend in ROE over FY21-22.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.